Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

A parenting expert has given five top tips to help parents adjust to a quieter household as millions of students prepare to ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Diet plays such a crucial role in managing – and, in some cases, reversing – prediabetes that you ignore it at your peril.

Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetesWith a single sensor, the ...

Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the Eversense 365 system provides one year of use, versus ...

Four years later they launched FreeStyle Libre, a reimagined continuous glucose ... Today more than 500 million people have diabetes, an autoimmune disease that causes the pancreas to produce ...

Diet plays such a crucial role in managing – and, in some cases, reversing – prediabetes that you ignore it at your peril.

Meanwhile, the UK launch of Freestyle Libre 3 comes as rival real-time CGM player Dexcom received a European CE mark for its G7 device for people with diabetes aged two years and older.